Paul Hastings advised Morgan Stanley, Goldman Sachs and China Merchant Securities as the joint sponsors in Ascletis Pharma’s US$400 million global offering and Hong Kong IPO,...
Ascletis Pharma’s $400 Million Initial Public Offering
BeiGene Ltd.’s $903 Million Public Offering on the Hong Kong Stock Exchange
Davis Polk advised the underwriters and the joint global coordinators in the public offering of BeiGene, Ltd. on the Hong Kong Stock Exchange. The gross proceeds...
KKR’s $530 Million Acquisition of Ramky Enviro Engineers Limited
Barclays and EY are acting as REEL and KKR’s M&A advisors, respectively. Link Legal serves as REEL’s legal counsel, and PwC and Transaction Square act as...
NongHyup Bank’s $500 Million Notes Offering
Simpson Thacher, acting as sole international counsel, represented Société Générale, as arranger and dealer, and BNP Paribas, Citigroup Global Markets Inc., Commerzbank Aktiengesellschaft, Crédit Agricole Corporate...
Yunfeng Fund III’s $2.5 Billion Fundraising
Simpson Thacher represented Yunfeng Capital in connection with the formation of Yunfeng Fund III, its third Greater China-focused private equity fund. The fund focuses primarily on...
Heineken’s €1.9 Billion Non-Binding Agreements with China Resources
Davis Polk is advising Heineken N.V. in connection with its non-binding agreements with China Resources Enterprise (“CRE”) and China Resources Beer (Holdings) Co. Ltd. (“CR Beer”)...
Vanke Service’s $180 Million Investment in Cushman & Wakefield
Davis Polk advised Vanke Service (HongKong) Co., a subsidiary of China Vanke, on its subscription for 4.9% of the ordinary shares of Cushman & Wakefield plc...
Aurora Mobile’s $71.7 million Initial Public Offering
Simpson Thacher represented the underwriters including, Goldman Sachs (Asia) L.L.C. and Credit Suisse, in connection with the initial public offering and listing on the NASDAQ Global...
Hope Education Group’s $389.7 Million Initial Public Offering
Davis Polk advised Hope Education Group Co., Ltd. in connection with its initial public offering and listing on the Hong Kong Stock Exchange and an international...
Fusen Pharmaceutical’s $53.3 Million Initial Public Offering
Simpson Thacher represented the underwriters in the initial public offering and Regulation S offering by Fusen Pharmaceutical Company Limited (“Fusen Pharmaceutical”). Fusen Pharmaceutical offered an aggregate...
KKR Consortium’s $1.56 billion Acquisition of LCY Chemical
Simpson Thacher is acting as lead counsel to a consortium led by KKR to acquire all of the issued and outstanding shares of LCY Chemical Corp....
Qeeka Home’s $150.5 Million Hong Kong IPO and Rule 144A/Regulation S Offering
Simpson Thacher represented the underwriters in the initial public offering in Hong Kong and Rule 144A/Regulation S offering by Qeeka Home (Cayman) Inc. (“Qeeka Home”). Qeeka...